WINNIPEG, Manitoba - (April 24, 2003) - Medicure Inc.
(TSX:MPH), a cardiovascular drug discovery and development company,
is pleased to announce that it will be presenting at BioFinance
2003 in Toronto. The Medicure presentation will take place Wednesday,
May 14, 2003 at 10:30 a.m. EDT in the Trinity II meeting room of
the Marriott Hotel, Eaton Centre in downtown Toronto.
BioFinance 2003 is the Canadian forum for some of the most innovative
companies, scientists and management teams in the life sciences
industry. More than 100 Canadian, U.S and European life sciences
and biotechnology companies will be presenting at the two-day event.
"We are delighted to be presenting at BioFinance 2003, one
of Canada's foremost biotech and life sciences conferences,"
said Albert D. Friesen, Ph.D, Medicure Chairman, President and CEO.
"We believe we have a very exciting and positive story to tell
and we look forward to the opportunity of meeting with the financial
community, other life sciences and biotech companies, industry officials,
and reporters and editors."
BioFinance was founded in 1997 as the scientific symposium of the
Canadian Medical Discoveries Fund. It has grown in size and prestige
over the years to a point where in 2002 it attracted 550 participants
and 100 presenting companies. It offers participants the opportunity
to hear leading-edge industry executives outline their development
plans for new technologies and medicines in a variety of fields.
About Medicure
Inc.
Medicure Inc. is a cardiovascular
drug discovery and development Company focused on developing effective
therapeutics for unmet needs in the field of cardiovascular medicine
including the prevention and treatment of ischemia, ischemic reperfusion
injury, and stroke.
This press release
contains forward-looking statements that involve risks, which may
cause actual results to differ materially from the statements made,
and accordingly may be deemed to be forward-looking statements made
pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. The forward-looking statements are
made as of the date hereof, and the Company disclaims any intention
and has no obligation or responsibility to update or revise any
forward-looking statements, whether as a result of new information,
future events, or otherwise.
For more information, please contact:
Derek Reimer
Chief Financial Officer
Don Bain
Director of Investor & Public Relations
Medicure Inc.
888-435-2220
204-488-9823 fax
info@medicure.com
Back to 2003 News Archives
